BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33069760)

  • 1. Flavonoids targeting NRF2 in neurodegenerative disorders.
    Khan H; Tundis R; Ullah H; Aschner M; Belwal T; Mirzaei H; Akkol EK
    Food Chem Toxicol; 2020 Dec; 146():111817. PubMed ID: 33069760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds.
    Denzer I; Münch G; Friedland K
    Pharmacol Res; 2016 Jan; 103():80-94. PubMed ID: 26626189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches.
    Sivandzade F; Prasad S; Bhalerao A; Cucullo L
    Redox Biol; 2019 Feb; 21():101059. PubMed ID: 30576920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Nrf2 signaling in counteracting neurodegenerative diseases.
    Dinkova-Kostova AT; Kostov RV; Kazantsev AG
    FEBS J; 2018 Oct; 285(19):3576-3590. PubMed ID: 29323772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases.
    Maher P
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
    Johnson DA; Johnson JA
    Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimethyl fumarate: A review of preclinical efficacy in models of neurodegenerative diseases.
    Majkutewicz I
    Eur J Pharmacol; 2022 Jul; 926():175025. PubMed ID: 35569547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases.
    Zhao J; Zhu M; Kumar M; Ngo FY; Li Y; Lao L; Rong J
    CNS Neurol Disord Drug Targets; 2019; 18(2):103-114. PubMed ID: 30394219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS.
    Petri S; Körner S; Kiaei M
    Neurol Res Int; 2012; 2012():878030. PubMed ID: 23050144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function.
    Esteras N; Dinkova-Kostova AT; Abramov AY
    Biol Chem; 2016 May; 397(5):383-400. PubMed ID: 26812787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting structural features of selected flavonoids responsible for neuroprotection in a Drosophila model of Parkinson's disease.
    Maitra U; Conger J; Owens MMM; Ciesla L
    Neurotoxicology; 2023 May; 96():1-12. PubMed ID: 36822376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthohumol Analogues as Potent Nrf2 Activators against Oxidative Stress Mediated Damages of PC12 Cells.
    Bai F; Zhang B; Hou Y; Yao J; Xu Q; Xu J; Fang J
    ACS Chem Neurosci; 2019 Jun; 10(6):2956-2966. PubMed ID: 31116948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases.
    Mandel S; Weinreb O; Amit T; Youdim MB
    J Neurochem; 2004 Mar; 88(6):1555-69. PubMed ID: 15009657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders.
    Yang Y; Jiang S; Yan J; Li Y; Xin Z; Lin Y; Qu Y
    Cytokine Growth Factor Rev; 2015 Feb; 26(1):47-57. PubMed ID: 25280871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases.
    Xiang Y; Song X; Long D
    Arch Toxicol; 2024 Mar; 98(3):579-615. PubMed ID: 38265475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner.
    Zhang B; Wang G; He J; Yang Q; Li D; Li J; Zhang F
    J Neuroinflammation; 2019 Apr; 16(1):92. PubMed ID: 31010422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases.
    George M; Tharakan M; Culberson J; Reddy AP; Reddy PH
    Ageing Res Rev; 2022 Dec; 82():101756. PubMed ID: 36243357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective potential of phase II enzyme inducer diallyl trisulfide.
    Sun MM; Bu H; Li B; Yu JX; Guo YS; Li CY
    Neurol Res; 2009 Feb; 31(1):23-7. PubMed ID: 18768114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection by urate on the mutant hSOD1-related cellular and Drosophila models of amyotrophic lateral sclerosis: Implication for GSH synthesis via activating Akt/GSK3β/Nrf2/GCLC pathways.
    Zhang C; Yang Y; Liang W; Wang T; Wang S; Wang X; Wang Y; Jiang H; Feng H
    Brain Res Bull; 2019 Mar; 146():287-301. PubMed ID: 30690059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.